<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>9 children with collagenoses were first treated with AHLG "Dessau" in combination with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and then with Imurek (<z:chebi fb="2" ids="2948">azathioprine</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>The children seemed to be vitally endangered and suffered from <z:e sem="disease" ids="C0234959" disease_type="Disease or Syndrome" abbrv="">panarteritis</z:e>, <z:e sem="disease" ids="C0011633" disease_type="Disease or Syndrome" abbrv="">dermatomyositis</z:e>, <z:e sem="disease" ids="C0151859" disease_type="Disease or Syndrome" abbrv="">polyserositis</z:e> or <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>-resistent systemic <z:hpo ids='HP_0005681'>juvenile rheumatoid arthritis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>As assessed by decrease of <z:mp ids='MP_0001845'>inflammation</z:mp> and clinical symptoms the treatment appeared in one case to be very good and in another good; in four other children it was good for a short period; in three children there was no effect at <z:hpo ids='HP_0000001'>all</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Side effects occurred relatively frequently (<z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:e sem="disease" ids="C0340865" disease_type="Disease or Syndrome" abbrv="">anaphylactoid reactions</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>The justification of an immuno-suppressive treatment together with anti-human-lymphocyte-globulin is discussed in relation to todays knowledge of the pathogenesis of collagenoses and of the mechanisms behind the effects of the AHLG </plain></SENT>
</text></document>